Search Results
Results found for "Gillman lab"
- Nanobodies: New Dimensions in GPCR Signaling Research
K., Gellman, S. H., Pautsch, A., Steyaert, J., Weis, W. I., & Kobilka, B. K. (2011).
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
biophysical fragment screening using polymer-encapsulated nanodiscs Google DeepMind And Isomorphic Labs
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
Gilman, A.G., G proteins: transducers of receptor-generated signals.
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
In every lab, candidates fail not because they lack potency at a receptor, but because they stumble at
- 📰 GPCR Weekly News, February 27 to March 5, 2023
AI-Driven Approach to Modern Drug Discovery Arcoscreen will present in the start-up village at Future Labs
- 📰 GPCR Weekly News, December 18 to 31, 2023
NEW Principal Investigator, In Vitro Biology NEW Associate Scientist Postdoctoral Scholar - O’Neill Lab
- 📰 GPCR Weekly News, December 11 to 17, 2023
World Congress of Basic and Clinical Pharmacology 2026 GPCR Jobs NEW Postdoctoral Scholar - O’Neill Lab
- 📰 GPCR Weekly News, October 30 to November 4, 2023
Hannes Schihada and his lab team developed fluorescent analogues for real-time binding studies of orphan
- 📰 GPCR Weekly News, May 29 to June 4, 2023
of Glioblastoma Associate Director / Director, Clinical Operations Postdoctoral Research Associate Lab
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
By using two labeled ligands the transference of energy event will only happen when the adequate distance are bound to is promiscuous, it will not compromise assay integrity the same way it would in single-label
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
A new contributor article from our friends at Celtrays Research outlines how dual-labeled fluorescent Dual-label specificity blocks promiscuous ligand confusion Lanthanide donors + d2 acceptors = high SNR
- Why Opposing Processes Matter for Your Next GPCR Drug
System-Dependent Activity and Opposing Processes Partial agonists don’t wear single labels.
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
This applied article walks through ligand-directed labeling, SNAP/Halo tags, and fluorescent ligands Assay flexibility: Combine self-labeling tags with quantitative readouts (e.g., TR-FRET) to expand mechanism
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
Flow Cytometry validation performed in the Oncological Pharmacology Laboratory of the University of Turin
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
Ligand-directed labelling strategies are a newly developed way to attach a fluorescent tag to a GPCR Another strategy is the use of self-labelling tags such as SNAP-tag and HaloTag. This provides flexibility in labelling the GPCRs but may interfere with functional activity of the receptors Fluorescence Microscopy validation performed in the ONCOMET laboratory (Health Research Institute of
- Fluorescence Polarization in GPCR Research
they do not require complex equipment for analysis and plate readers are usually available in regular laboratories
- Advantages of Fluorescent Probes in GPCR Assays
Real-time dynamic labeling of A 2B AR. Representative confocal images of HCT116 cells pre-stained with CellTracker Green (lower panels) and labeled CAFs are labeled with CellTracker (Green), and cocultures are labeled with CELT-327 250 nM.
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
Because Tag-lite® is based on FRET, we have collaborated with BMG Labtech to develop an application note Assay Principle CELT-335 is a fluorescently labelled full agonist, which binds to the orthosteric site It binds to the receptor, which is labelled with Tb.
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
6 Kd calculated through saturation of CELT-335 in human HEK-293T cells transiently expressing Tb-labeled Tb labelling was performed as described in Materials and Methods. Tb labelling was performed as described in Materials and Methods. Directed Evolution of O6-Alkylguanine-DNA Alkyltransferase for Applications in Protein Labeling. A General Method for the Covalent Labeling of Fusion Proteins with Small Molecules in Vivo.
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
theory behind the assays FA is based on measuring the change in rotational freedom of the fluorescent label equilibrium properties of CELT-419 to D3R in BBVs FA assay, the ligand must have a suitable fluorescent label For example, some assays benefit from using a more red-shifted fluorescent label or a combination of multiple labels in a single study. For example, a Cy5-labelled fluorescent ligand with the same pharmacophore is available from Celtarys
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
You’d be tempted to label the first “competitive” and the second “non-competitive.”
- Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools
Celtarys Research develops high-quality, fluorescently labeled ligands and innovative chemical biology Their proprietary chemistry platform enables rapid generation of conjugates, such as labeled ligands,
- Mapping Motion: Intermediate States, Deorphanization & Discovery
Triple Labeling Resolves a GPCR Intermediate State by Using Three-Color Single Molecule FRET .
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
An important reason for this unfavourable situation is that laboratory experiments are performed under Dave K, Gelman H, Thu CT, Guin D, Gruebele M.
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
Heng , Xavier Deupi , Yang Du , Brian K Kobilka Red and far-red cleavable fluorescent dyes for self-labelling obesity drug caused up to 20% weight loss after a year, with no plateau INAUGURATION OF AELIS FARMA NEW LABORATORY cryo-EM structure determination of a Family A GPCR Red and far-red cleavable fluorescent dyes for self-labelling
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
Rivas-Santisteban , Ana Muñoz , Jaume Lillo , Iu Raïch , Ana Rodríguez-Pérez , Gemma Navarro , José Labandeira-García
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
including time, financial investment, and specialised expertise, limiting accessibility for some research laboratories BioRxiv (Cold Spring Harbor Laboratory) . https://doi.org/10.1101/2024.04.17.590000 Pines, G., Fankhauser
- APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking
Therefore, it’s a great molecular tool for proximity labeling approaches in living cells. During this process, APEX2 can label proteins in the vicinity, allowing the capture of a snapshot of After the labeling reaction, the researchers purified and biotinylated proteins (those that have been labeled by APEX2) and analyzed them using quantitative proteomics such as tandem mass tags.
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Updates in GPCR Research A nondestructive membrane engineering method using an amphiphilic polymer Labeling
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
may miss broader functional regions, while random mutagenesis generates extensive data that require labour-intensive






















